AIM
RVLP

Alambic Investment Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Alambic Investment Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,516
Closed -$68K – 52
2020
Q3 		$68K Sell
12,516
-35,456
-74% -$204K 0.75% 48
2020
Q2 		$323K Sell
47,972
-2,000
-4% -$9.79K 0.81% 42
2020
Q1 		$159K Sell
49,972
-23,635
-32% -$126K 0.38% 100
2019
Q4 		$515K Buy
73,607
+14,603
+25% +$77.9K 0.43% 84
2019
Q3 		$227K Buy
+59,004
New +$200K 0.17% 198

Other funds holding RVLP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Alambic Investment Management's RVLP Position: Q4 2020 in Review

Alambic Investment Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2020, closing a stake of 12,516 shares — an estimated $68K sold.

Alambic Investment Management first reported a position in RVLP in Q3 2019 and held it in 5 quarters. The position peaked at $515K in Q4 2019. 60 funds tracked by Wall St. Rank hold RVLP as of Q4 2020.

  • Alambic Investment Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 12,516 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2020, an estimated $68K.
  • Alambic Investment Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2019 and held it in 5 quarters.
  • Alambic Investment Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $515K in Q4 2019.
  • 60 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.